OptiNose has developed innovative nasal drug delivery devices that enable nasal administration of CNS (nose to brain), systemic and topical nasal formulations. Unlike traditional nasal inhalers, nasal sprays or nebulizers, our unique breath-powered devices deliver intranasal drugs to targeted regions of the nasal cavity, without lung deposition. We like to say “right drug” in the “right amount” in the “right place.”
Who should contact OptiNose?
- Pharmaceutical and biotech companies interested in evaluating the nasal polyps or migraine applications
- Those seeking an innovative delivery platform for their proprietary CNS, systemic, or topical nasal compounds